Vista Pharmaceuticals Limited (VISTAPH.BO)
INR 12.14
(3.67%)
INR 12.14
(3.67%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 102.87 Million | 10.03 Million | 3.94 Million | 12.66 Million | 227.59 Million | 310.72 Million |
| Cost of Revenue | 92.85 Million | 31.94 Million | 6.11 Million | 7.71 Million | 242.28 Million | 255.67 Million |
| Gross Profit | 10.02 Million | -21.9 Million | -2.16 Million | 4.94 Million | -14.69 Million | 55.05 Million |
| Operating Expenses | 20.16 Million | 16.9 Million | 16.09 Million | 29.52 Million | 46.74 Million | 50.12 Million |
| Selling, General and Administrative Expenses | 20.16 Million | 2.01 Million | 1.66 Million | 997 Thousand | 2.08 Million | 4.17 Million |
| Research and Development Expenses | - | - | - | - | - | 6.21 Million |
| Other Expenses | - | 2.85 Million | 1.65 Million | 948 Thousand | 35.9 Million | 16.24 Million |
| Cost and Expenses | 113.02 Million | 48.84 Million | 22.21 Million | 37.23 Million | 289.02 Million | 305.79 Million |
| Operating Income | -10.14 Million | -46.29 Million | -18.26 Million | -24.57 Million | -58.18 Million | 4.94 Million |
| Interest Expense | 12.19 Million | 13.09 Million | 8.97 Million | 15.44 Million | 13.64 Million | 15.61 Million |
| Income Tax Expense | -6.65 Million | -2.14 Million | -17.29 Million | -18.02 Million | -2.58 Million | 2.07 Million |
| Earnings before Tax | -51.77 Million | -58.76 Million | -26.17 Million | -38.11 Million | -39.36 Million | 11.47 Million |
| Net Income | -45.12 Million | -56.62 Million | -8.88 Million | -20.08 Million | -36.77 Million | 9.39 Million |
| Earnings Per Share Basic | -0.96 | -1.54 | -0.24 | -0.58 | -1.21 | 0.31 |
| Earnings Per Share Diluted | -0.96 | -1.54 | -0.24 | -0.58 | -1.21 | 0.30 |
| Weighted Average Shares Outstanding | 46.89 Million | 36.83 Million | 36.79 Million | 34.65 Million | 30.36 Million | 30.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 46.89 Million | 36.83 Million | 36.79 Million | 34.65 Million | 30.36 Million | 30.87 Million |
| Gross Margin | 0.10 | -2.18 | -0.55 | 0.39 | -0.06 | 0.18 |
| EBIT Margin | -0.31 | -3.32 | -2.80 | -1.22 | -0.05 | 0.15 |
| Profit Margin | -0.44 | -5.64 | -2.25 | -1.59 | -0.16 | 0.03 |
| EBITDA | -32.37 Million | -40.45 Million | -11.01 Million | -15.34 Million | -10.49 Million | 18.58 Million |
| Earnings Before Tax Margin | -0.10 | -4.61 | -4.63 | -1.94 | -0.26 | 0.02 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 17.95 Million | 102.87 Million | 31.32 Million | 17.04 Million | 34.69 Million | 19.81 Million |
| Cost of Revenue | 22.35 Million | 113.89 Million | 21.43 Million | 28.5 Million | 32.07 Million | 19.69 Million |
| Gross Profit | -4.4 Million | -11.01 Million | 9.88 Million | -11.46 Million | 2.62 Million | 119 Thousand |
| Operating Expenses | 5.19 Million | 31.74 Million | 8.91 Million | 7.69 Million | 16.12 Million | 11.06 Million |
| Selling, General and Administrative Expenses | 5.19 Million | - | 8.91 Million | 7.69 Million | 7.4 Million | 5.15 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 711 Thousand | -2.56 Million | -2000.00 | 241 Thousand | 797 Thousand | 1.32 Million |
| Cost and Expenses | 27.54 Million | 145.63 Million | 30.35 Million | 36.2 Million | 48.2 Million | 30.75 Million |
| Operating Income | -9.59 Million | -42.75 Million | 974 Thousand | -19.15 Million | -11.06 Million | -10.94 Million |
| Interest Expense | 2.82 Million | 12.19 Million | 2.78 Million | 2.97 Million | 3.18 Million | 3.26 Million |
| Income Tax Expense | -3.14 Million | -6.65 Million | -1.89 Million | -5.72 Million | 4.3 Million | -3.34 Million |
| Earnings before Tax | -11.71 Million | -51.77 Million | -984 Thousand | -22.01 Million | -15.88 Million | -12.89 Million |
| Net Income | -8.57 Million | -45.12 Million | 907 Thousand | -16.28 Million | -20.19 Million | -9.54 Million |
| Earnings Per Share Basic | -0.15 | - | 0.02 | -0.35 | -0.46 | -0.22 |
| Earnings Per Share Diluted | -0.15 | - | 0.01 | -0.35 | -0.46 | -0.22 |
| Weighted Average Shares Outstanding | 57.13 Million | 46.89 Million | 46.89 Million | 46.89 Million | 43.89 Million | 42.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.13 Million | 46.89 Million | 46.89 Million | 46.89 Million | 43.89 Million | 42.76 Million |
| Gross Margin | -0.25 | -0.11 | 0.32 | -0.67 | 0.08 | 0.01 |
| EBIT Margin | -0.43 | - | 0.09 | -1.02 | -0.31 | -0.40 |
| Profit Margin | -0.48 | -0.44 | 0.03 | -0.96 | -0.58 | -0.48 |
| EBITDA | -7.76 Million | - | 2.77 Million | -17.32 Million | -10.88 Million | -7.89 Million |
| Earnings Before Tax Margin | -0.53 | -0.42 | 0.03 | -1.12 | -0.32 | -0.55 |
CVVRF
ACIIN
PWRMF
THURF
WYCC
FGAS